BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24401661)

  • 1. Global target mRNA specification and regulation by the RNA-binding protein ZFP36.
    Mukherjee N; Jacobs NC; Hafner M; Kennington EA; Nusbaum JD; Tuschl T; Blackshear PJ; Ohler U
    Genome Biol; 2014 Jan; 15(1):R12. PubMed ID: 24401661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of TTP and HuR plays an important role in cancers.
    Wang H; Ding N; Guo J; Xia J; Ruan Y
    Tumour Biol; 2016 Nov; 37(11):14451-14461. PubMed ID: 27644249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity.
    Moore MJ; Blachere NE; Fak JJ; Park CY; Sawicka K; Parveen S; Zucker-Scharff I; Moltedo B; Rudensky AY; Darnell RB
    Elife; 2018 May; 7():. PubMed ID: 29848443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages.
    Lu YC; Chang SH; Hafner M; Li X; Tuschl T; Elemento O; Hla T
    Cell Rep; 2014 Dec; 9(6):2330-43. PubMed ID: 25533351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells.
    Zhang Z; Guo M; Li Y; Shen M; Kong D; Shao J; Ding H; Tan S; Chen A; Zhang F; Zheng S
    Autophagy; 2020 Aug; 16(8):1482-1505. PubMed ID: 31679460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AU-rich element landscape across human transcriptome reveals a large proportion in introns and regulation by ELAVL1/HuR.
    Bakheet T; Hitti E; Al-Saif M; Moghrabi WN; Khabar KSA
    Biochim Biophys Acta Gene Regul Mech; 2018 Feb; 1861(2):167-177. PubMed ID: 29413897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins.
    Hitti E; Bakheet T; Al-Souhibani N; Moghrabi W; Al-Yahya S; Al-Ghamdi M; Al-Saif M; Shoukri MM; Lánczky A; Grépin R; Győrffy B; Pagès G; Khabar KS
    Cancer Res; 2016 Jul; 76(14):4068-80. PubMed ID: 27197193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival.
    Upadhyay R; Sanduja S; Kaza V; Dixon DA
    Int J Cancer; 2013 Feb; 132(3):E128-38. PubMed ID: 22907529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Transcriptional Regulation of Immune Responses and Inflammatory Diseases by RNA-Binding ZFP36 Family Proteins.
    Makita S; Takatori H; Nakajima H
    Front Immunol; 2021; 12():711633. PubMed ID: 34276705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phylogenetic distribution and evolution of the linked RNA-binding and NOT1-binding domains in the tristetraprolin family of tandem CCCH zinc finger proteins.
    Blackshear PJ; Perera L
    J Interferon Cytokine Res; 2014 Apr; 34(4):297-306. PubMed ID: 24697206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.
    Al-Ahmadi W; Al-Ghamdi M; Al-Souhibani N; Khabar KS
    J Pathol; 2013 May; 230(1):28-38. PubMed ID: 23401122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
    Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
    Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells.
    Tu Y; Wu X; Yu F; Dang J; Wang J; Wei Y; Cai Z; Zhou Z; Liao W; Li L; Zhang Y
    BMC Immunol; 2019 May; 20(1):13. PubMed ID: 31046669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global analysis of RNA-protein interactions in TNF-α induced alternative splicing in metabolic disorders.
    Louis JM; Agarwal A; Aduri R; Talukdar I
    FEBS Lett; 2021 Feb; 595(4):476-490. PubMed ID: 33417721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells.
    Al-Souhibani N; Al-Ghamdi M; Al-Ahmadi W; Khabar KS
    Carcinogenesis; 2014 Sep; 35(9):1983-92. PubMed ID: 24692066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminating between HuR and TTP binding sites using the k-spectrum kernel method.
    Bhandare S; Goldberg DS; Dowell R
    PLoS One; 2017; 12(3):e0174052. PubMed ID: 28333956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.
    Al-Souhibani N; Al-Ahmadi W; Hesketh JE; Blackshear PJ; Khabar KS
    Oncogene; 2010 Jul; 29(29):4205-15. PubMed ID: 20498646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tristetraprolin targets Nos2 expression in the colonic epithelium.
    Eshelman MA; Matthews SM; Schleicher EM; Fleeman RM; Kawasawa YI; Stumpo DJ; Blackshear PJ; Koltun WA; Ishmael FT; Yochum GS
    Sci Rep; 2019 Oct; 9(1):14413. PubMed ID: 31595002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
    Guo J; Lei M; Cheng F; Liu Y; Zhou M; Zheng W; Zhou Y; Gong R; Liu Z
    Cell Death Dis; 2020 Jun; 11(6):413. PubMed ID: 32487989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mRNA-destabilizing protein Tristetraprolin targets "meiosis arrester"
    Xi G; An L; Wang W; Hao J; Yang Q; Ma L; Lu J; Wang Y; Wang W; Zhao W; Liu J; Yang M; Wang X; Zhang Z; Zhang C; Chu M; Yue Y; Yao F; Zhang M; Tian J
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34031239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.